ProPhase Labs, Inc. develops and commercializes novel drugs, dietary supplements, and compounds in the United States. It operates through two segments: Diagnostic Services and Consumer Products. The company provides a range of TK supplements, including Legendz XL for male sexual health; and Triple Edge XL, an energy and stamina booster. It offers contract manufacturing services, such as product development, pre-commercialization, production, warehousing, and distribution; COVID-19 diagnostic information services to a range of customers, including health plans, third party payers, and government organizations; and respiratory pathogen panel molecular and DNA testing services, as well as personal genomics products and services. In addition, the company involved in the research, development, manufacture, distribution, marketing, and sale of over the counter (OTC) consumer healthcare products and dietary supplements; and retail operations. The company was formerly known as The Quigley Corporation. ProPhase Labs, Inc. was founded in 1989 and is headquartered in Garden City, New York.

Market Cap	$12.05M	P/E Ratio	NaN
52W High	$6.66	52W Low	$0.07
Div Yield	N/A	Payout Ratio	N/A
EPS Growth 3Y	-100.0%	52W Position	0.3%
Overall Score	42	Value Score	60
Quality Score	39	Technical Score	27

EPS Current Est	$NA	EPS Next Est	$NA
EPS Growth Est	N/A	DPS Growth 3Y	N/A

	A	B	C	D
1	Symbol	Price	Change	Volume
2	PRPH	$0.09	-21.30%	4.91K
3
4
5

	A	B	C	D
1	Symbol	Price	Change	Vol
2	PRPH	$0.09	-21.3%	4.91K
3
4
5
6

PRPH

PRPH

Key Metrics Overview

Growth Analysis

Revenue (5Y)

EBITDA (5Y)

Get ProPhase Labs Inc. Data in Excel

Get ProPhase Labs Inc. Data in Excel